Publications by authors named "J Lesperance"

Claim this Profile
I
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.
Jacqueline Lesperance, Bryan S Yung, Michael M Allevato, Marcus M Cheng, Maria F Camargo

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia.
Karina Hamamoto, Ganqian Zhu, Qian Lai, Julia Lesperance, Huacheng Luo

J Clin Invest· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment.
Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani

Molecules· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology.
Qian Lai, Karina Hamamoto, Huacheng Luo, Zachary Zaroogian, Caixian Zhou, Julia Lesperance

Leukemia· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy.
Dina V Hingorani, Michael M Allevato, Maria F Camargo, Jacqueline Lesperance, Maryam A Quraishi

Nat Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis